Two Sigma Investments, LP Seres Therapeutics, Inc. Transaction History

Two Sigma Investments, LP

$40.3 Billion
Q1 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.93 - $2.15 $313,929 - $725,751	337,559 Added 2806.21%	349,588 $489,000
Q3 2023 Nov 14, 2023	BUY	$2.33 - $5.07 $28,027 - $60,987	12,029 New	12,029 $28,000
Q2 2022 Aug 15, 2022	BUY	$2.7 - $7.62 $561,340 - $1.58 Million	207,904 Added 162.23%	336,056 $1.15 Million
Q1 2022 May 16, 2022	BUY	$6.3 - $8.84 $388,098 - $544,570	61,603 Added 92.57%	128,152 $912,000
Q4 2021 Feb 14, 2022	SELL	$6.02 - $11.43 $5.62 Million - $10.7 Million	-932,867 Reduced 93.34%	66,549 $554,000

Q3 2021 Nov 15, 2021	BUY	$5.46 - $22.6 $4.59 Million - $19 Million	840,214 Added 527.77%	999,416 $6.96 Million
Q2 2021 Aug 16, 2021	SELL	$18.46 - $24.36 $935,903 - $1.24 Million	-50,699 Reduced 24.15%	159,202 $3.8 Million
Q1 2021 May 17, 2021	BUY	$17.66 - $28.92 $1.23 Million - $2.01 Million	69,391 Added 49.39%	209,901 $4.32 Million
Q4 2020 Feb 16, 2021	BUY	$23.25 - $37.73 $2.63 Million - $4.27 Million	113,182 Added 414.16%	140,510 $3.44 Million
Q3 2020 Nov 16, 2020	SELL	$3.74 - $28.74 $490,392 - $3.77 Million	-131,121 Reduced 82.75%	27,328 $774,000
Q2 2020 Aug 14, 2020	BUY	$3.04 - $6.2 $344,121 - $701,827	113,198 Added 250.16%	158,449 $754,000
Q1 2020 May 15, 2020	SELL	$2.64 - $3.82 $175,116 - $253,388	-66,332 Reduced 59.45%	45,251 $162,000
Q4 2019 Feb 14, 2020	BUY	$2.99 - $4.42 $46,877 - $69,296	15,678 Added 16.35%	111,583 $385,000
Q3 2019 Nov 14, 2019	SELL	$2.29 - $4.16 $172,501 - $313,364	-75,328 Reduced 43.99%	95,905 $385,000
Q2 2019 Aug 14, 2019	BUY	$2.28 - $7.35 $267,770 - $863,206	117,443 Added 218.34%	171,233 $551,000
Q1 2019 May 15, 2019	BUY	$4.83 - $7.21 $172,532 - $257,548	35,721 Added 197.69%	53,790 $370,000
Q4 2018 Feb 14, 2019	BUY	$4.52 - $8.88 $81,671 - $160,452	18,069 New	18,069 $82,000
Q3 2018 Nov 14, 2018	SELL	$7.33 - $9.23 $181,769 - $228,885	-24,798 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$6.91 - $9.55 $171,354 - $236,820	24,798 New	24,798 $213,000
Q1 2018 May 15, 2018	SELL	$7.34 - $11.16 $282,186 - $429,046	-38,445 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$9.15 - $12.64 $249,291 - $344,376	27,245 Added 243.26%	38,445 $390,000
Q3 2017 Nov 14, 2017	BUY	$12.81 - $16.85 $143,472 - $188,720	11,200	11,200 $180,000

Others Institutions Holding MCRB

# of Institutions

100

Shares Held

62.7M

Call Options Held

36.9K

Put Options Held

476K

Flagship Pioneering Inc. Cambridge, MA

23.1M
Shares

$16.6 Million
1.17% of portfolio
Black Rock Inc. New York, NY

6.83M
Shares

$4.91 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

6.73M
Shares

$4.85 Million
0.0% of portfolio
Hudson Bay Capital Management LP Greenwich, CT

5.43M
Shares

$3.91 Million
0.03% of portfolio
Geode Capital Management, LLC Boston, MA

2.13M
Shares

$1.54 Million
0.0% of portfolio

View Full List

About Seres Therapeutics, Inc.

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $89.3M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

More about MCRB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account